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Background: The Swedish National Tobacco Quitline (SNTQ), which has both a proactive and a reactive service,
has successfully provided tobacco cessation support since 1998. As there is a demand for an increase in national
cessation support, and because the quitline works under funding constraints, it is crucial to identify the most
clinically effective and cost-effective service. A randomized controlled trial was performed to compare the effectiveness
of the high-intensity proactive service with the low-intensity reactive service at the SNTQ.
Methods: Those who called the SNTQ for smoking or tobacco cessation from February 2009 to September 2010 were
randomized to proactive service (even dates) and reactive service (odd dates). Data were collected through postal
questionnaires at baseline and after 12 months. Those who replied to the baseline questionnaire constituted the study
base. Outcome measures were self-reported point prevalence and 6-month continuous abstinence at the 12-month
follow-up. Intention-to-treat (ITT) and responder-only analyses were performed.
Results: The study base consisted of 586 persons, and 59% completed the 12-month follow-up. Neither ITT- nor
responder-only analyses showed any differences in outcome between proactive and reactive service. Point prevalence
was 27% and continuous abstinence was 21% in analyses treating non-responders as smokers, and 47% and 35%,
respectively, in responder-only analyses.
Conclusion: Reactive service may be used as the standard procedure to optimize resource utilization at the SNTQ.
However, further research is needed to assess effectiveness in different subgroups of clients.
Trial registration: ClinicalTrials.gov: NCT02085616
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Tobacco control remains a critical public health chal-
lenge, and encouraging smoking cessation is crucial to
reducing mortality and morbidity [1]. Evidence-based
smoking cessation treatments exist but are underutilized,
and an important issue is to meet the individual needs of
the smokers [2]. A number of problems and barriers for
cessation work and methods are identified among health-
care professionals as well as among smokers [3,4]. Tele-
phone counselling is an evidence-based option that is
both effective and cost-effective [2,5-9]. Quitlines have* Correspondence: eva.nohlert@ltv.se
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unless otherwise stated.an extensive range, the potential to reach underserved
populations, and an important function in supporting the
health-care system to help patients quit smoking [2,6].
They are usually free of charge for the caller and offer
both a reactive service, in which only incoming calls are
attended, and a proactive service, which offers a number
of callbacks [5]. According to meta-analyses, the odds of
quitting are 40% higher for smokers who call quitlines and
receive multiple proactive counselling than for controls
who receive brief counselling or mailed self-help materials.
There is evidence of a dose–response relationship [2,10]
and clearer evidence of benefits for smokers who are
motivated to quit, but no difference is found between
different types of counselling methods and adjunctive
self-help materials [2,5,10]. However, in the most recentLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ber of calls [9], and for the English national quitline,
the additional effect of offering more intensive proactive
counselling compared with standard care is unclear [11,12].
Because there are considerable differences in quitline
treatment protocols, organization, and techniques in dif-
ferent countries, yet, international comparisons are diffi-
cult [8,10,13].
In Sweden, the prevalence of adult daily smoking has
steadily declined since the 1980s to 11% in 2012. Yet,
1.6 million Swedes use tobacco (cigarettes and/or snus
[moist snuff]) every day, and 6,600 persons die in smoking-
related diseases every year (18 per day) [14]. The supply
of smoking cessation support will be the most import-
ant component of the tobacco control work to reduce
smoking-related mortality in coming decades. However,
the need for cessation support is greater than can be
managed with the present resources. Furthermore, there
are large regional differences in the supply of cessation
support [15].
The Swedish National Tobacco Quitline (SNTQ) is a
nationwide, free service operated by the Stockholm
County Council Health Service and financed by the
Swedish Government. The quitline started in 1998 with
a reactive service. In 1999, a proactive service was intro-
duced, and clients could choose a reactive or proactive
service. Previous studies report about a 30% point preva-
lence abstinence (responder-only) at 12-month follow-
up, a cost per life-year saved of about 400 USD, and that
the proactive service is significantly more effective than
the reactive service for women but not for men [16,17].
However, these results are based on non-randomized
studies in which clients could choose which service they
wanted.
Given the reach of the quitline to meet the increased
national demand for cessation support, and its current
funding constraints, it is crucial that the most clinically
effective and cost-effective service is identified. To study
the effectiveness of the two services at the SNTQ, a ran-
domized controlled trial (RCT) started in 2009. The aim
was to compare the effectiveness of the high-intensity




The SNTQ operates two or three lines 51 hours per week,
Monday-Thursday 9 am -8 pm and Friday 9 am-4 pm.
The number of calls per year is about 10,000 but fluctu-
ates quite a lot with varying marketing activities. About
40% are not treatment calls; these include e.g., brief ques-
tions, and calls from relatives and health-care personnel.
The number of new treatment clients is normally about
2000 per year. All calls are registered in a computerizeddatabase. When a tobacco user calls to discuss his/her
own tobacco behaviour, the counsellor asks whether the
client would like to sign up for cessation support. If the
client gives verbal consent, their preference of callback
(proactive service) or no callback (reactive service) is re-
corded, and a registration form, which includes the base-
line questionnaire, is mailed to them. A returned baseline
questionnaire is regarded as informed consent and the cli-
ent is included in a study base to assess effectiveness. The
baseline information is registered in computerized client
records in accordance with common rules of confidential-
ity. Printed material partly tailored to the client’s needs
and motivation to quit is offered free of charge. Twelve
months after the first call, a follow-up questionnaire is
sent by mail to the client. Non-responders to the baseline
or follow-up questionnaire receive up to two reminders,
one by mail, and one by telephone.
Counselling
The counsellors are trained health professionals, such as
nurses, dentists, dental hygienists, or psychologists, with
previous experience of primary and secondary preven-
tion. Additionally, all counsellors receive approximately
6 months of training in tobacco cessation methods. The
structured treatment protocol is a mixture of motiv-
ational interviewing (MI), cognitive behaviour therapy,
and pharmacological consultation. Regular call monitor-
ing with supervision is performed for quality assurance
and an independent university-based coding laboratory
also assess the quality (fidelity) of MI. Twenty counsel-
lors offered treatment during the study period, of which
eight had more than 20 clients, nine had 5–20 clients,
and three had less than five clients.
The present RCT
In total, 1212 calls to the SNTQ were classified as new
treatment calls during the inclusion period from February
2009 to September 2010, inclusive. Calls from clients
who had called some time during the past ten years were
not classified as new treatment calls. Snus cessation calls
were excluded, leaving 1129 for randomization, 588 to
proactive service and 541 to reactive service. The study
was performed within the normal run of the SNTQ with
the only difference that callers were not offered a choice
of callbacks or no callbacks. Instead were only those call-
ing on even dates offered callbacks, thus proactive service,
and those calling on odd dates were informed that they
could themselves call back whenever they liked, thus re-
active service. The only difference between the two treat-
ment groups was the offer to be called back. As the
randomization was performed at the time for the clients’
first call, the intervention has started and was known by
the clients when they decided to return the baseline ques-
tionnaire and thus be included in the study base, giving
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domized to proactive service, 73% wanted to be called
back. Of callers randomized to reactive service, 13% re-
ceived callbacks. As the proactive service implies an offer
to be called back, both those who did and those who did
not want to be called back were included in the study.
However, the reactive service implies that there is no offer
to be called back, so those who received callbacks were
excluded from the study. The study base consisted of the
586 clients who returned the baseline questionnaire, 303
of whom were allocated to the proactive service group
and 283 to the reactive service group (Figure 1).
Questionnaires and outcomes
The questionnaires included questions about the use of
cigarettes, snus, and pharmaceuticals, different aspects
of present and previous smoking habits and quitting
attempts, exposure to second-hand smoke, and access
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Figure 1 Flow chart of the study. Clients included from February 2009 to
in the follow-up questionnaire for one individual.questionnaire also included three questions that asked
the participants to rate themselves on a Visual Analog
Scale from 1 = “not at all likely” to 10 = “very likely”. The
questions were 1) “The probability that I will be com-
pletely smoke-free in one year?” 2) “I can handle stress
and depression without smoking” and 3) “I will use phar-
maceuticals to control tobacco cravings if necessary”.
Three further questions in the baseline questionnaire
assessed to what extent the client experienced that the
counsellor 1) was a keen listener, 2) tried to understand
the client’s needs, 3) showed respect for the client’s own
goals. The response alternatives were “a lot”, “quite a lot”,
“to some extent”, and “not at all”. “A lot” for all the three
questions was required for “high” level of satisfaction in
the analyses.
Abstinence was assessed with two questions: 1) “Have
you smoked (one or more deep drags) during the past
7 days?” with response alternatives of “no, not at all”,
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September 2010, inclusive. *Internal drop-out for outcome variables
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“0-7 days ago”, “more than 7 days but less than 6 months
ago”, “6-12 months ago”, and “more than 12 months
ago”. Outcome measures were point prevalence abstin-
ence (not a puff in the last week) and 6-month continu-
ous abstinence (not a puff in the last 6 months) at the
12-month follow-up.
The study was approved by the Ethical Committee at
Karolinska Institutet (Dnr 00–367).
Data analysis
Power calculations estimated that approximately 2500
smokers were required to detect an expected difference
of 5% of units between the arms with 80% power, assum-
ing a point prevalence of 30% in the reactive arm. To
compensate for loss to follow-up, it was decided to
randomize about 3000 clients. Approximately 19 months
into the data collection a preliminary analysis was done,
to assess if there were any trends in outcome towards
the original hypothesis that would warrant continued
data collection in accordance with the previous power
calculations. This analysis revealed no effect of the pro-
active service over the reactive and thus it was decided
to discontinue new recruitment to the study.
SPSS (version 20) was used for statistical analyses and
statistical significance was set at p < .05 (two-sided). Abstin-
ence at follow-up was measured i) according to intention-
to-treat (ITT), where non-responders to the follow-up
questionnaire were treated as smokers and ii) in responders
only. Continuous variables were compared using either
parametric t-tests or non-parametric Mann–Whitney U-
tests. Categorical variables were compared with chi-square
tests. Logistic regression analysis was performed to calcu-
late odds ratios (ORs) with a 95% confidence interval for
the two abstinence measures. Univariable analyses were
performed for all relevant independent variables, and
those found to be statistically significant at p < .2 were
included in the multivariable analyses with service,
gender, and age. The multivariable analyses were per-
formed with forward and backward stepwise selection,
to detect potential collinearity that could disturb the
analyses, with 5% for inclusion and 5% for exclusion.
Hosmer and Lemeshow goodness of fit test was used
to test the overall fit of the logistic regression model
[18]. Two regression models were performed for each
abstinence measure, one predictive that merely included
the variables known at baseline and one descriptive that
also included variables describing what happened in the
subsequent year. From the descriptive models, we had
to exclude two variables because of too many missing
observations; duration of call number 2 from the point
prevalence model, and snus use in the week before 12-
month follow-up from the 6-month continuous abstin-
ence model.Results
Fifty-nine per cent of the study base returned the 12-
month follow-up questionnaire, 55% in the proactive
and 64% in the reactive service (p = .015). The flow chart
of the study is presented in Figure 1.
The typical caller in the present study was a 50-year-
old woman with 12 years of education who had been
a daily smoker for 30 years. Population characteristics
at baseline are presented in Table 1. The number of
calls and the total call duration was significantly higher
in the proactive than in the reactive service; however,
the duration of first call was equal in both services
(Table 2).
There were no statistically significant differences in
outcome between proactive and reactive service at the
12-month follow-up, in either point prevalence or con-
tinuous abstinence, or in either ITT or responder-only
analyses. Of those who responded to the 12-month
follow-up, 47% were point prevalence abstinent and 35%
were continuously abstinent (Table 3).
The predictive model from the multivariable logistic
regression analyses, which included only the variables
known at baseline, showed that not smoking the week
before baseline was the strongest predictor for both
point prevalence (OR 3.2) and continuous abstinence
(OR 3.7) at the 12-month follow-up. The ability to han-
dle stress and depression without smoking was also a
statistically significant predictor (upper part of Table 4).
In the descriptive model, which included all variables
until the 12-month follow-up, variables significant for
point prevalence were i) not smoking the week before
baseline, ii) the ability to handle stress and depression
without smoking, iii) high level of client satisfaction at the
first call, and iv) gender (female). Variables significant
for continuous abstinence were i) not smoking the week
before baseline, which had the strongest effect (OR 5.4),
ii) baseline assessment of probability of being smoke-
free in 1 year, and iii) not using NRT in the past week be-
fore follow-up (lower part of Table 4). The results of the
univariable analyses for the two outcomes are presented
in Additional file 1: Table S1 and Additional file 2:
Table S2.
In drop-out analyses, we compared baseline charac-
teristics of responders (n = 347) with non-responders
(n = 239) to the 12-month follow-up. Responders were
significantly more often in the reactive service, older,
smoke-free at the first call, pharmaceutical users, and not
exposed to second-hand smoke. They also smoked fewer
cigarettes/day but had been smokers for a greater
number of years. In a separate unpublished analysis
of contacted responders and non-responders to the
12-month follow-up, we found that 54% (36/67) of re-
sponders were point prevalence abstinent 2.5-4 years
after the first call, compared with 32% (14/44) of
Table 1 Population characteristics at baseline
Total Proactive Reactive p-value
N = 586 npro = 303 nre = 283
Gender: women (%, n/N) 78 (457/586) 79 (238/303) 77 (219/283) .734*
Age groups (%, n/N):
≤ 34 20 (115/576) 21 (64/301) 19 (51/275) .118*
35-49 25 (142/576) 27 (82/301) 22 (60/275)
50-64 39 (223/576) 38 (114/301) 40 (109/275)
≥ 65 17 (96/576) 14 (41/301) 20 (55/275)
Education in years (%, n/N):
0-9 25 (142/570) 23 (67/296) 27 (75/274) .400*
10-12 42 (237/570) 42 (125/296) 41 (112/274)
≥ 13 33 (191/570) 35 (104/296) 32 (87/274)
Number of cig/day (data journal) (%, n/N):
0 27 (131/482) 24 (60/248) 30 (71/234) .268*
1-14 34 (163/482) 36 (90/248) 31 (73/234)
≥ 15 39 (188/482) 39 (98/248) 39 (90/234)
No smoking the past seven days at baseline (%, n/N) 28 (161/583) 26 (78/301) 29 (83/282) .342*
Number of years smoked before baseline (md, q1−q3, N) 33, 18–40, 552 30, 16–40, 290 35, 20–43, 262 .024
†
Stages-of-change (%, n/N):
-precontemplation/contemplation 19 (81/433) 18 (41/229) 20 (40/204) .872*
-preparation 29 (127/433) 30 (69/229) 28 (58/204)
-action 52 (225/433) 52 (119/229) 52 (106/204)
Exposed to passive smoking (%, n/N) 26 (142/552) 28 (81/285) 23 (61/267) .134*
Drug use (NRT, Zyban®, Champix®) the week before baseline (%, n/N) 52 (294/568) 53 (156/295) 51 (138/273) .578*
Snus use the week before baseline (%, n/N) 7 (36/526) 9 (24/274) 5 (12/252) .070*
Other support (%, n/N):
- none 28 (162/574) 28 (82/296) 29 (80/278) .600*
- social 46 (264/574) 44 (131/296) 48 (133/278)
- professional 11 (60/574) 12 (35/296) 9 (25/278)
- social + professional 15 (88/574) 16 (48/296) 14 (40/278)
High level of client satisfaction at first contact (%, n/N)‡ 81 (447/554) 79 (228/288) 82 (219/266) .346*
Probability for being smokefree in one year (1–10) (md, q1−q3, N) 8, 7–10, 564 9, 7–10, 292 8, 7–10, 272 .209
†
Handle stress and depression successfully without smoking (1–10) (md, q1−q3, N) 7, 4–9, 564 7, 4–9, 293 7, 4–9, 271 .565
†
Will use pharmaceuticals if necessary (1–10) (md, q1−q3, N) 9, 5–10, 566 9, 5–10, 293 10, 5–10, 273 739
†
*Statistical significant difference between proactive and reactive service tested with chi-square test.
†Statistical significant difference between proactive and reactive service tested with Mann–Whitney U-test.
‡Three questions: 1. The counsellor was understanding and sensitive, 2. The counsellor tried to understand my needs, 3. The counsellor showed respect for my
own targets and decisions. Four response alternatives: much, rather, to some extent, not at all. Much for all the three questions was required for “much” and high
level of client satisfaction in the analyses.
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Equal effectiveness was found in the proactive and react-
ive services at the SNTQ in the present study, and
smoking status at baseline was the strongest predictor
for abstinence at 12 months.Effectiveness
Almost half of those who responded to the 12-month
had been smoke-free in the previous 7 days, and a third
had been smoke-free for the past 6 months, in both the
proactive and reactive service groups (Table 3). The effect-
iveness of the SNTQ has continuously improved over
time, from below 30% to almost 40% in point prevalence
among clients responding to the 12-month follow-up [19].
The present study indicates a further improvement. Even
Table 2 Number and length of calls
Total Proactive Reactive p-value
N = 586 npro = 303 nre = 283
Number of calls
Mean (SD) 3.2 (4.6) 4.3 (4.7) 2.1 (4.3) < .001*
Median (q1-q3) 2.0 (1.0-3.0) 3.0 (2.0-5.0) 2.0 (1.0-2.0) < .001
†
Range 1-70 1-40 1-70
1 call (%, n/N) 34 (198/586) 19 (57/303) 50 (141/283) < .001‡
2 calls 31 (182/586) 27 (81/303) 36 (101/283)
3 calls 11 (67/586) 15 (47/303) 7 (20/283)
Number of calls, 3 groups (%, n/N)
≤ 2 65 (380/586) 45 (138/303) 85 (242/283) < .001‡
3-6 25 (145/586) 37 (111/303) 12 (34/283)
≥ 7 10 (61/586) 18 (54/303) 3 (7/283)
Total length of calls (minutes)
Mean (SD) 47.9 (58.3) 60.1 (65.7) 34.8 (45.8) < .001*
Median (q1-q3) 31.0 (20.7-52.0) 38.0 (24.0-71.0) 27.0 (18.0-38.0) < .001
†
Range 5-707 6-591 5-707
Length of first call (minutes):
Mean (SD) 25.1 (10.7) 25.2 (10.7) 25.0 (10.9) .859*
Median (q1-q3) 23.0 (17.0-31.0) 23.0 (18.0-31.0) 23.0 (17.0-31.0) .820
†
Range 5-75 6-60 5-75
Length of second call (minutes) (N = 389) (n = 246) (n = 143)
Mean (SD) 8.6 (9.5) 9.6 (9.7) 6.8 (8.9) .004*
Median (q1-q3) 6.0 (1.0-13.0) 8.0 (2.0-14.3) 2.0 (0.0-12.0) .001
†
Range 0-61 0-61 0-40
*Statistical significant difference between proactive and reactive service tested with t-test.
†Statistical significant difference between proactive and reactive service tested with Mann–Whitney U-test.
‡Statistical significant difference between proactive and reactive service tested with chi-square test.
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siderable differences in treatment protocols, organization,
and techniques [8,10,13], the effectiveness in the present
study compares favourably with most other reports, even
those including NRT [2,5,8,10,11,20-22]. The specific def-
inition used to define the study base at the SNTQ, yet, al-
ways has to be taken into consideration when comparing
results to other quitlines. The equal effectiveness of theTable 3 Abstinence at the 12-month follow-up
% (n/N) Total
N = 586
Response rate 59 (347/586)
Point prevalence ITT* 27 (161/586)
Point prevalence responder-only 47 (161/346)
Continuous abstinence ITT* 21 (121/586)
Continuous abstinence responder-only 35 (121/346)
*Intention-to-treat. Abstinence measured in the whole study base, non-responders
†Statistical significant difference between proactive and reactive service tested withtwo services is somewhat surprising and in contrast to a
number of international studies showing higher effective-
ness for more intensive and proactive services [2,5]. How-
ever, it is in accordance with a recent study on the English
quitline, which shows no additional effect of proactive
counselling on abstinence after 6 months [11].
As Table 2 shows, there were significantly more calls,
and consequently, significantly longer counselling duration,Proactive Reactive p-value†
npro = 303 nre = 283
55 (165/303) 64 (182/283) .015
26 (78/303) 29 (83/283) .331
47 (78/165) 46 (83/181) .792
20 (60/303) 22 (61/283) .600
36 (60/165) 34 (61/181) .604
at 12-month follow-up treated as smokers.
chi-square test.
Table 4 Multivariable logistic regression analysesa for point prevalence abstinence and 6-month continuous abstinence
Predictive model (variables at baseline related to being smoke-free at follow-up)
Point prevalence abstinenceb 6-month continuous abstinencec
Variable OR (95% CI) p-value OR (95% CI) p-value
Service, proactive vs. reactive (ref.) 0.7 (0.5-1.1) .149 0.8 (0.5-1.3) .423
Gender, men vs. women (ref.) 0.6 (0.4-1.0) .061 0.7 (0.4-1.2) .181
Age
≤ 34 (ref.) 1.0 .846f 1.0 .748f
35-49 1.2 (0.7-2.1) .578 1.3 (0.7-2.6) .374
50-64 1.2 (0.7-2.1) .552 1.2 (0.6-2.2) .584
≥ 65 0.9 (0.5-1.9) .884 1.0 (0.4-2.1) .927
Smoked in the week before baseline, no vs. yes (ref.) 3.2 (2.1-4.9) <.001 3.7 (2.3-5.9) < .001
Handle stress and depression without smoking (baseline assessment, 1–10) 1.1 (1.04-1.2) .003 1.2 (1.1-1.3) < .001
Descriptive model (all variables related to being smoke-free at follow-up)
Point prevalence abstinenced 6-month continuous abstinencee
Variable OR (95% CI) p-value OR (95% CI) p-value
Service, proactive vs. reactive (ref.) 0.7 (0.5-1.1) .163 0.7 (0.4-1.4) .386
Gender, men vs. women (ref.) 0.6 (0.3-0.99) .046 0.6 (0.3-1.1) .111
Age
≤ 34 (ref.) 1.0 .896f 1.0 .363f
35-49 1.1 (0.6-2.1) .674 0.9 (0.4-2.2) .896
50-64 1.1 (0.6-1.9) .741 0.8 (0.4-1.8) .612
≥ 65 0.9 (0.4-1.8) .770 0.4 (0.1-1.2) .111
Smoked in the week before baseline, 3.1 (2.0-4.9) <.001 5.4 (3.0-9.7) < .001
No vs. yes (ref.)
Handle stress and depression without smoking (baseline assessment, 1–10) 1.1 (1.02-1.2) .014 — —
Probability of being smoke-free in 1 year (baseline assessment, 1–10) — — 1.3 (1.1-1.6) < .001
Level of client satisfaction at first contact, 2.2 (1.2-4.0) .013 — —
High vs. other (ref.)
NRT use in the week before 12-month follow-up, yes vs. no (ref.) — — 0.2 (0.1-0.5) < .001
aPerformed with service, gender and age forced into both models.
bN = 555, Nagelkerke R-Square 15.7%. Hosmer and Lemeshow test of goodness of fit, p = .057.
cN = 555, Nagelkerke R-Square 19.2%. Hosmer and Lemeshow test of goodness of fit, p = .265.
dN = 536, Nagelkerke R-Square 17.0%. Hosmer and Lemeshow test of goodness of fit, p = .365.
eN = 310, Nagelkerke R-Square 33.9%. Hosmer and Lemeshow test of goodness of fit, p = .621.
fp-value for the total effect of the variable with 3 df.
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would mean that the proactive service has an advan-
tage, according to meta-analyses of telephone counsel-
ling, which show that increased intensity yields higher
abstinence rates [2,5,10]. A difference in call volume is
not obvious in practice, because participants using the re-
active service can call many times and participants using
the proactive service do not always accept or receive all
scheduled calls [10,11,22].
Smoking status at baseline was the strongest predictor
for abstinence at 12 months in the present study. Being
smoke-free in the week prior to baseline increased the
odds for abstinence by 3 to 5 times (Table 4). Nicotine
dependence is usually simply measured as the numberof cigarettes smoked per day, and is a frequently reported
predictor in smoking cessation studies [2]. Unfortu-
nately, the information on this variable from the data
journal was invalid, and the question was not included
in the baseline questionnaire. However, the baseline smok-
ing status may be an appropriate alternative, because
callers to a quitline are more prepared and motivated
to quit than smokers in the general population and
smokers in clinical trials [16,23], and therefore can be
smoke-free relatively often at first contact. A confirm-
ation was that different information sources were com-
parable; at first call 24% reported being tobacco-free
and 27% reported no (0) smoked cigarettes/day, and
at baseline 28% reported being smoke-free in the past
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reactive services.
A meta-analysis of 22 studies finds that proactive tele-
phone counselling has a significant adjunct effect to other
minimal interventions for younger, male, light-smoking
participants [24]. None of the study characteristics related
to intervention process, such as number of calls and mi-
nutes per call, significantly explained variations in out-
come. An implication of that analysis is the need to focus
on participants as much as on intervention processes to
obtain more effective interventions. The rationale for the
present study was the need to make the best use of limited
resources, and one way would be to provide treatment re-
lated to individual performance. We found no differences
between the two services for gender or different age
groups. This contrasts with the previously mentioned, but
non-randomized SNTQ study where the proactive service
is found to be more effective in women than in men [16].
Possible explanations
There are a number of possible explanations for the ob-
served equal effectiveness of the proactive and reactive
services in the present study. The SNTQ already had a
relatively high success rate and this may be one possible
reason for the lack of difference between the service al-
ternatives. Everyone calling the SNTQ has initiated a call
in the first place, indicating that their motivation to quit
may be higher than that of the average smoker trying to
quit or of smokers recruited to cessation studies. Ap-
proximately every fourth caller were smoke-free at base-
line in both services, and these people probably have the
highest motivation which is supported by the finding
that the “smoke-free at baseline” variable was the most
important predictive factor for abstinence after 1 year in
our regression analyses (Table 4).
The length of the first call was equal in both services
(Table 2), and it is certainly possible that the high quality
of the initial interviews may have been a factor in redu-
cing the difference between the services. During the time
of the present study high quality MI was delivered in
both services according to laboratory coding. Adding high
quality MI to the SNTQ treatment protocol is found to
significantly enhance the already relatively high treatment
outcome by approximately 5%, in a previous controlled
clinical trial [19]. The present results suggest that clients
reporting a high level of satisfaction at first contact were
twice as likely to be point prevalent abstinent after 1 year
(Table 4). There was no significant difference between the
services regarding level of client satisfaction.
The reactive service at the SNTQ has, to some extent,
a proactive element in it because all clients are followed
up after 12 months, and the effect of the 12-month
follow-up per se is unknown. There was a higher re-
sponse rate at the 12-month follow-up in the reactiveservice group than the proactive service group. This differ-
ence in response rate is not yet explained and is somewhat
surprising, because recruitment and follow-up routines
were the same for both groups. If anything, these differ-
ences may underestimate the effectiveness of the proactive
service compared with the reactive service, because re-
sponders may be more likely to be smoke-free at follow-
up as demonstrated in the higher abstinence rates in
responder-only compared with ITT-analyses (Table 3).
NRT and snus
The long-term effectiveness of NRT seen in clinical trials
has been questioned when used in real-world settings
and in general populations [11,25,26]. In the present
study, we found no effect of NRT use between the first
call and the 12-month follow-up in the multivariable ana-
lyses, which is consistent with results from the English
national quitline study [11]. On the contrary, those who
used NRT in the week before the follow-up were signifi-
cantly less likely to be continuously abstinent (Table 3). A
possible explanation can be that these NRT users were in
a new or repeated quit attempt at the time of follow-up,
since it concerned continuous abstinence but not point
prevalence abstinence.
Snus is debated as a means for smoking cessation and
seems to play a different role for smokers who quit with
professional support than it does for self-quitters [16,27-29].
In the present clinical setting, only 7% of the participants
used snus the week before baseline and 7% used it the
week before 12-month follow-up, and we found no effect
of snus use on abstinence in the multivariable analyses.
This is consistent with previous data from the SNTQ [16].
Methodological matters, strengths and limitations
Quitline trials are, in most cases, effectiveness trials be-
cause they are conducted within the context of operating
quitlines, and therefore under relatively real-world con-
ditions [5,13]. The present study was the first attempt at
the SNTQ to randomize clients within the normal run-
ning activity to assess if offering proactivity would en-
hance quit rates. As randomization was performed on
even and odd dates, thus at the time for the client’s first
call, the intervention had started before the client was
included in the study, as a returned baseline question-
naire is required for inclusion in the SNTQ study base.
The definition of the SNTQ study base has remained
constant from the start in 1998, to enable comparisons
of changes in outcome with changes in the treatment
protocol over time. Whereas this may be a strength for
the internal development of the SNTQ service, it may be
a potential problem when comparing SNTQ results with
other smoking cessation services.
Under real-world conditions, many practical factors
such as invalid phone numbers and missed appointments
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in a study such as the present, even human factors such as
forgetfulness, specific wishes, and the considerations of
callers and counsellors can end in protocol violation. Thir-
teen per cent of those randomized to reactive service actu-
ally received proactive service, a figure that ought to be
zero, and those clients had to be excluded from the study.
A possible explanation is the randomization procedure to
proactive service on even dates and to reactive service on
odd dates, which required the counsellors to remember
and then strictly abide by what was stated in the protocol.
The equal effectiveness of both services in the ITT- as
well as the responder-only analyses is a strength of the
present study. The study was terminated before reaching
the required number of clients according to the power
calculation. A part-time analysis was entered in the
syllabus and this analysis revealed no additional effect of
the proactive service over the reactive, thus it was de-
cided to discontinue new recruitment to the study.
A limitation regarding validity is the self-report of ab-
stinence, which may overestimate quit rates. However,
self-reports are considered accurate in most smoking
cessation studies and are rarely differential across inter-
vention conditions. Biochemical verification is not re-
quired and may not be desirable in studies where the
optimal data collection methods are through mail, tele-
phone, or the Internet [30]. The tradition in evaluating
smoking cessation programmes is to treat non-responders
as smokers. It is a conservative approach that will not
overestimate treatment effects. However, a previous study
of non-responders of the SNTQ indicates that it may also
underestimate the true treatment effect [31]. The response
rate of 59% at the 12-month follow-up is a matter of con-
cern. Although follow-up procedures have not changed,
SNTQ response rates have decreased over time from
about 70% to 60% [16,19]. Even if relatively normal in
studies like this [8], there is a possibility for bias due
to differential loss to follow-up, especially in light of
the described differences between responders and non-
responders.
Conclusion
To optimize resource utilization at the SNTQ, the react-
ive service may be preferred as the first treatment of
choice. However, more research is needed to assess
whether the proactive service may be favourable for sub-
groups of clients.
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